Annual Drug Patent Expirations for VANCOMYCIN+HYDROCHLORIDE
Vancomycin Hydrochloride is a drug marketed by Akorn, Fresenius Kabi Usa, Lupin Ltd, Orient Pharma Co Ltd, Strides Pharma, Watson Labs, Aspiro, Emcure Pharms Ltd, Eugia Pharma, Gland Pharma Ltd, Hainan Poly, Hainan Poly Pharm, Hikma, Hikma Pharms, Hospira, Hospira Inc, Knack, Meitheal, Mylan Labs Ltd, Pharm Assoc, Sagent Pharms, Sandoz, Sandoz Inc, Teva Pharms Usa, Xellia Pharms Aps, and Samson Medcl and, and is included in forty-seven NDAs. It is available from twenty suppliers. There are three patents protecting this drug.
This drug has thirty-three patent family members in twenty-seven countries.
The generic ingredient in VANCOMYCIN HYDROCHLORIDE is vancomycin hydrochloride. Twenty suppliers are listed for this compound. Additional details are available on the vancomycin hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
